TTD | Drug: D0M0IQ

Drug General Information
Drug ID	D0M0IQ
Former ID	DNC004860
Drug Name	Bis-(5-pyridin-3-yl-thiophen-2-ylmethyl)-amine
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[527367]
Structure		Download 2D MOL 3D MOL
Formula	C20H17N3S2
Canonical SMILES	C1=CC(=CN=C1)C2=CC=C(S2)CNCC3=CC=C(S3)C4=CN=CC=C4
InChI	1S/C20H17N3S2/c1-3-15(11-21-9-1)19-7-5-17(24-19)13-23-14-18-6-8-20(25-18)16-4-2-10-22-12-16/h1-12,23H,13-14H2
InChIKey	CKCZUAVVHJHNJY-UHFFFAOYSA-N
PubChem Compound ID	11210706
Target and Pathway
Target(s)	Cytochrome P450 2D6	Target Info	Inhibitor	[527367]
KEGG Pathway	Metabolism of xenobiotics by cytochrome P450
	Drug metabolism - cytochrome P450
	Serotonergic synapse
Reactome	Xenobiotics
WikiPathways	Metapathway biotransformation
	Tamoxifen metabolism
	Oxidation by Cytochrome P450
	Vitamin D Receptor Pathway
	Aripiprazole Metabolic Pathway
	Fatty Acid Omega Oxidation
	Codeine and Morphine Metabolism
References
Ref 527367	J Med Chem. 2005 Jan 13;48(1):224-39.5-substituted, 6-substituted, and unsubstituted 3-heteroaromatic pyridine analogues of nicotine as selective inhibitors of cytochrome P-450 2A6.
Ref 527367	J Med Chem. 2005 Jan 13;48(1):224-39.5-substituted, 6-substituted, and unsubstituted 3-heteroaromatic pyridine analogues of nicotine as selective inhibitors of cytochrome P-450 2A6.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.

Drug Information